| A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran AZ Momeni, T Jalayer, M Emamjomeh, A Khamesipour, F Zicker, ... Vaccine 17 (5), 466-472, 1999 | 199 | 1999 |
| Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection S Ajdary, MH Alimohammadian, MB Eslami, K Kemp, A Kharazmi Infection and immunity 68 (4), 1760-1764, 2000 | 180 | 2000 |
| Effect of Ti-containing inclusions on the nucleation of acicular ferrite and mechanical properties of multipass weld metals M Fattahi, N Nabhani, M Hosseini, N Arabian, E Rahimi Micron 45, 107-114, 2013 | 139 | 2013 |
| Leishmania species: detection and identification by nested PCR assay from skin samples of rodent reservoirs AA Akhavan, H Mirhendi, A Khamesipour, MH Alimohammadian, Y Rassi, ... Experimental parasitology 126 (4), 552-556, 2010 | 119 | 2010 |
| Comparative safety and immunogenicity trial of two killed Leishmania major vaccines with or without BCG in human volunteers K Bahar, Y Dowlati, B Shidani, MH Alimohammadian, A Khamesipour, ... Clinics in dermatology 14 (5), 489-495, 1996 | 79 | 1996 |
| Dynamics of Leishmania infection rates in Rhombomys opimus (Rodentia: Gerbillinae) population of an endemic focus of zoonotic cutaneous leishmaniasis in Iran AA Akhavan, MR Yaghoobi-Ershadi, A Khamesipour, H Mirhendi, ... Bulletin de la Société de pathologie exotique 103 (2), 84-89, 2010 | 71 | 2010 |
| Mechanisms Controlling Anaemia in Trypanosoma congolense Infected Mice HA Noyes, MH Alimohammadian, M Agaba, A Brass, H Fuchs, ... PLoS One 4 (4), e5170, 2009 | 70 | 2009 |
| Comparison of chitosan, alginate and chitosan/alginate nanoparticles with respect to their size, stability, toxicity and transfection A Rafiee, MH Alimohammadian, T Gazori, F Riazi-rad, SMR Fatemi, ... Asian Pacific Journal of Tropical Disease 4 (5), 372-377, 2014 | 68 | 2014 |
| Molecular epidemiology of cutaneous leishmaniasis and heterogeneity of Leishmania major strains in Iran H Mahmoudzadeh‐Niknam, S Ajdary, F Riazi‐Rad, E Mirzadegan, ... Tropical Medicine & International Health 17 (11), 1335-1344, 2012 | 66 | 2012 |
| Comparative analysis of CD4+ and CD8+ T cells in tumor tissues, lymph nodes and the peripheral blood from patients with breast cancer FR Rad, S Ajdary, R Omranipour, MH Alimohammadian, ZM Hassan Iranian biomedical journal 19 (1), 35, 2015 | 65 | 2015 |
| Characterization of Leishmania species and L. major strains in different endemic areas of cutaneous leishmaniasis in Iran R ESHRATKHAH, D IRANI Iranian Biomedical Journal 7 (2), 43-50, 2003 | 65 | 2003 |
| Molecular epizootiology of rodent leishmaniasis in a hyperendemic area of Iran AA Akhavan, MR Yaghoobi-Ershadi, H Mirhendi, MH Alimohammadian, ... Iranian journal of public health 39 (1), 1, 2010 | 55 | 2010 |
| Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection MHM Hoseini, M Moradi, MH Alimohammadian, VK Shahgoli, H Darabi, ... Parasitology international 65 (2), 99-104, 2016 | 47 | 2016 |
| In vitro and in vivo activities of Peganum harmala extract against Leishmania major P Rahimi-Moghaddam, SA Ebrahimi, H Ourmazdi, M Selseleh, ... Journal of research in medical sciences: the official journal of Isfahan …, 2011 | 45 | 2011 |
| Toll-like receptor 4 polymorphisms predispose to cutaneous leishmaniasis S Ajdary, MM Ghamilouie, MH Alimohammadian, F Riazi-Rad, SR Pakzad Microbes and infection 13 (3), 226-231, 2011 | 40 | 2011 |
| The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis MH Alimohammadian, A Khamesipour, H Darabi, A Firooz, S Malekzadeh, ... Vaccine 21 (3-4), 174-180, 2002 | 40 | 2002 |
| Leishmania major lipophosphoglycan: discrepancy in toll-like receptor signaling G Kavoosi, SK Ardestani, A Kariminia, MH Alimohammadian Experimental parasitology 124 (2), 214-218, 2010 | 37 | 2010 |
| Canine visceral leishmaniasis: seroprevalence survey of asymptomatic dogs in an endemic area of northwestern Iran M Barati, M Mohebali, MH Alimohammadian, A Khamesipour, B Akhoundi, ... Journal of Parasitic Diseases 39, 221-224, 2015 | 34 | 2015 |
| Assessment of interferon-γ levels and leishmanin skin test results in persons recovered for leishmaniasis MH Alimohammadian, SL Jones, H Darabi, F Riazirad, S Ajdary, ... The American journal of tropical medicine and hygiene 87 (1), 70, 2012 | 34 | 2012 |
| Evaluation of the efficacy of Iran leishmanin and comparison with leishmanins from Wellcome (UK) and Roma (Italy) in cured cutaneous leishmaniasis patients. MH Alimohammadian, M Kivanjah, F Pak, A Gaznavia, A Kharazmi | 33 | 1993 |
